Similar articles

• A trial comparing nucleoside monotherapy with sequential therapy with 3 drugs in HIV-infected patients.

  Roca B, Olmos P, Mínguez C, Arnedo A, Usó J, Teruel C, Segarra M, Sáez-Royuela A, Simón E. Roca B, et al. Scand J Infect Dis. 1998;30(4):426-8. doi: 10.1080/00365549850160792. Scand J Infect Dis. 1998. PMID: 9817530 Clinical Trial.
• [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].

  Aguirrebengoa K, Mallolas J, Uriz J, Torres Tortosa M. Aguirrebengoa K, et al. Enferm Infecc Microbiol Clin. 1996 Oct;14 Suppl 1:3-9. Enferm Infecc Microbiol Clin. 1996. PMID: 9053024 Review. Spanish. No abstract available.
• Treatment of late-state HIV infection.

  Millard PS. Millard PS. J Fam Pract. 1997 Feb;44(2):132-4. J Fam Pract. 1997. PMID: 9040512 No abstract available.
• Drugs for HIV infection.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2000 Jan 10;42(1069):1-6. Med Lett Drugs Ther. 2000. PMID: 10683666 No abstract available.
• [Anti-retroviral treatment. Treatment modification: toxicity management].

  Ocaña I, Laguna F, Pulido F, Bascuñana A. Ocaña I, et al. Enferm Infecc Microbiol Clin. 1996 Oct;14 Suppl 1:31-5. Enferm Infecc Microbiol Clin. 1996. PMID: 9053025 Review. Spanish. No abstract available.